Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 14,268 |
|
|||||
| News | - | ||||||
| Day High | 2.56 | Low High |
|||||
| Day Low | 2.38 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Incannex Healthcare Ltd | IXHL | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.16 | -6.27% | 2.39 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.51 | 2.38 | 2.56 | 2.39 | 2.55 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 212 | 14,268 | US$ 2.48 | US$ 35,389 | - | 0.80 - 12.68 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:25:31 | 49 | US$ 2.3806 | USD |
Incannex Healthcare Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 793.66k | 15.87M | - | 1.01M | -19.98M | -1.26 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Incannex Healthcare News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/16/2024 | 07:00 | GlobeNewswire Inc. | Incannex Healthcare Inc. Quarterly Update, Q1 2024 |
| 2/28/2024 | 06:30 | GlobeNewswire Inc. | Incannex Announces Positive Topline Results from Phase 2.. |
| 2/16/2024 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/16/2024 | 06:30 | GlobeNewswire Inc. | Incannex Completes Successful Pre-IND Meeting with the FDA.. |
| 2/14/2024 | 05:16 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 2/01/2024 | 06:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/01/2024 | 06:30 | GlobeNewswire Inc. | Clarion Clinics Open for Psychedelic-Assisted Treatments |
| 1/24/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/24/2024 | 15:05 | GlobeNewswire Inc. | Incannex Commences Dosing in Phase 2 Clinical Trial.. |
| 1/18/2024 | 08:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/18/2024 | 07:22 | GlobeNewswire Inc. | Incannex Completes Dosing and Therapy in Phase 2 “PsiGAD”.. |
| 1/17/2024 | 06:30 | GlobeNewswire Inc. | Incannex Receives IRB Approval for the RePOSA Phase 2/3.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IXHL Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.23 | 2.94 | 2.20 | 2.64 | 19,507 | 0.16 | 7.17% |
| 1 Month | 3.50 | 3.50 | 2.13 | 2.70 | 19,438 | -1.11 | -31.71% |
| 3 Months | 3.28 | 8.4697 | 2.13 | 5.71 | 339,563 | -0.89 | -27.13% |
| 6 Months | 1.07 | 12.68 | 0.80 | 5.85 | 197,785 | 1.32 | 123.36% |
| 1 Year | 2.00 | 12.68 | 0.80 | 4.86 | 130,571 | 0.39 | 19.50% |
| 3 Years | 11.00 | 90.00 | 0.80 | 7.22 | 90,040 | -8.61 | -78.27% |
| 5 Years | 11.00 | 90.00 | 0.80 | 7.22 | 90,040 | -8.61 | -78.27% |
Incannex Healthcare Description
| Incannex Healthcare Ltd is developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. |
